2022.Apr.08
Corporate
Poster Presentations at AACR 2022 Annual Meeting for OBI-3424 and Globo H Science
Title: OBI-3424, an AKR1C3-activated prodrug, exhibits in vivo synergistic anti-tumor effect in combination with pembrolizumab by induction of immunogenic cell death Poster number: 6111 / Abstract number: 2922 Title: High Globo-H expression associated with poor survival of gastric cancer patients and enriched PD-L1 expression Poster Number: 6138 / Abstract number: 1742
This article is password protected.
To view the content, please enter your password in the field below